维普中文期刊产品整合服务
30篇 您的检索式:作者名="Sandor V"
    题名 作者 年代 出处 被引量
1Phase I trial of the histone deacetylase inhibitor, depsipeptide ( FR901228, NSC630176), in patients with refractory neoplasms 显示文摘SANDOR V BAKKE S ROBERT W 2002Clin Cancer Res2002,8,3:1
2P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228显示文摘Sandor V Senderowicz A Mertins S 2000Br J Cancer2000,83,6:1
3Adipose stem cell tissue- engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration显示文摘Sandor GK Tuovinen V J Wolff J 2013J Oral Maxillofac Surg2013,71,5:1
4Quantitation the diastereoisomers of Luthionine(R,S)-sulfoximine in human plasma: a validated assay by capillary electrophoresis 显示文摘 1995J Chromatogr Biored Appl1995,673,:1
5Inhibitor of histone deacetylation,depsipeptide(FR901228),in the treatment of peripheral and cutaneous T-cell lymphoma:a case report显示文摘Piekarz RL Robey R Sandor V 2001Blood2001,98,9:1
6Phase Ⅰ trial of the histone deacetylase inhibitor, depsipeptide ( FR901228, NSC 630176), in patients with refractory neoplasms显示文摘 Bakke S Robey RW 2002Clin Cancer Res2002,8,3:1
7P21-depen- dent G~ arrest with downregnlation of cyclin D1 and upre- gulation of cyclin E by the histone deacetylase inhibitor FR901228显示文摘Sandor V Senderowicz A Mertins S 2000Br J Cancer2000,83,6:1
8Inhibitor of histone deacetylation,depsipeptide (FR901228),in the treatment of peripheral and cutaneous T-cell lymphoma:a case report显示文摘Piekarz RL Robey R Sandor V Bakke S Wilson WH Dahmoush L 2001Blood2001,98,9:1
9Phase Ⅰ trial of the histone deacetylase inhibitor,depsipeptide(FR901228,NSC630176),in patients with refractory neoplasms显示文摘Sandor V Bakke S Robey R 2002Clin Cancer Res2002,8,3:1
10Synchronous inflammatory breast cancer and advanced ovarian carcinoma:a case with prolonged disease-free survival显示文摘Sandor V Reed E Sarosy G 1999Ann Oncol1999,10,5:1
11Inhibitor of histone deacetylatio depsipeptide (FR901228) in the treatment of peripheral and cutaneous T cell lymphoma:a case report显示文摘Piekarz RL Robey R Sandor V 2001Blood2001,98,9:1
12Regional and seasonal differences in light absorption by yellow substance in the Southern Bight of the North Sea显示文摘RODERICK E W WINFRIED W C SANDOR V L 1999Journal of Sea Research1999,42,:1
13Role of ultrasonography in the urgent differential diagnosis of acute scrotum显示文摘Sandor L Gajda T Aranyi V 2011Orv Hetil2011,152,23:1
14P21-dependent g(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228显示文摘SANDOR V SENDEROWICZ A MERTINS S 2000BrJ Cancer2000,83,6:1
15Inhibition of carnitine biosynthesis by valproic acid in rats-the biochemical mechanism of inhibition显示文摘Farkas V Bock I Cseko J Sandor A 1996Biochem Pharmacol1996,52,9:1
16The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding 显示文摘KRAGOL G SANDOR L GYORGYI V 2001Biochemistry2001,40,:1
17Phase Ⅱ trail of chemotherapy alone for PCNSL and intraocular lymphoma显示文摘Sandor V Stark V Pearson D 1998J Clin Oncol1998,16,:1
18Evaluation of cor- porate environment management approaches A framework and ap- plication显示文摘GYULA V SANDOR K DENNIS A R 1996Int J Production Economics1996,43,:1
19Inhibitor of histone deacetylation,depsipeptide (FR901228),in the treatment of peripheral and cutaneous T-cell lymphoma:a case report显示文摘PIEKARZ RL ROBEY R SANDOR V 2001Blood2001,98,9:1
20Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report 显示文摘Piekarz RL Robey R Sandor V 2001Blood2001,98,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费